Skip survey header

New CXM Global Event Survey-AM LIVE

1. Thank you for attending: Webinar Livtencity: A new approach for your post-transplant CMV patients
26 March 20:00 - 21:30

Please tell us: *This question is required.
Space Cell (1) Poor -- (7) Excellent
How relevant was the content shared and presented in this event?
How easy was it to follow the content in this event?
How logistically easy was it to attend this event (platform/location)?
How trustworthy do you consider the content shared and presented in this event?
How logistically easy was it to attend this event (Location)?
How logistically easy was it to attend this event (Platform)?
This event is sponsored by Takeda Pharmaceuticals International AG.
The content of the training is independently prepared by the Center of Excellence, University Hospital Leuven, Belgium.
This event is for healthcare professionals only.
VV-MEDMAT-73023


 
This session is organised and funded by Takeda.
For healthcare professionals only.
Copyright ©2023 Takeda Pharmaceutical Company Limited. 
                                                                   All rights reserved
This Industry Interactive Discussion is open to healthcare professionals who attend the 36th ECNP Congress. 
This Industry Interactive Discussion has been initiated, organized, and funded by Takeda Pharmaceuticals International AG. 
Takeda Products may be mentioned.

Copyright 2023. Takeda Pharmaceutical Company Limited. All rights reserved. 
Takeda and the Takeda logo are registered trademarks of Takeda Pharmaceutical Company Limited, used under license.
VV-MEDMAT-73353
This event is initiated and funded by Takeda. It is intended exclusively for Healthcare Professionals and Laboratory Specialists (VV-MEDMAT-73023).
This event is open to healthcare professionals who attend ECNP 2022.
Thank you for attending: Webinar Livtencity: A new approach for your post-transplant CMV patients.


Please tell us:
  *This question is required.
Space Cell (1) Poor--(7) Excellent
Was the format of the advisory board meeting appropriate for your active contribution?
How appropriate was the format/channel of this event?
Did you have sufficient time for the preparatory work?
Were the instructions clear?
How logistically easy was it to attend this event (platform/location)?*
Space Cell (1) Poor -- (5) Excellent
Flights and transfers
Accomodation
Dinner 14th October
Dinner 15th October
Dinner 16th October
Which of the following symposiums have you attended? *This question is required.
How would you rate your satisfaction with the following components of your experience at ECCO 2024?
Space Cell (1) Not at all satisfied ........ (5) Very satisfied
Do you think that the first contact from the organizing agency took place in good time?
Are you satisfied with the organization overall?
Do you think the organizing agency paid particular attention to details (e.g. rooms, desk, transfers, etc.)?
How do you rate the first telephone contact you had with the organizing agency?
How do you rate the courtesy and helpfulness of the hostesses?
This meeting was initiated, organised, and funded by Takeda.
This meeting was for healthcare professionals and other relevant decision makers with an interest in ADHD in adults only.
Takeda’s medicines were discussed at this meeting.

Adverse events should be reported to the Medicines and Healthcare products Regulatory Agency. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Takeda at: AE.GBR-IRL@takeda.com.